HAP Trading, LLC - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 57 filers reported holding SIO GENE THERAPIES INC in Q1 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q1 2022$0
-100.0%
24,200
+128.3%
0.00%
Q4 2021$2,000
-50.0%
10,600
-23.7%
0.00%
Q3 2021$4,000
-75.0%
13,900
-59.0%
0.00%
Q4 2020$16,00033,9240.00%
Other shareholders
SIO GENE THERAPIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,969,987$8,108,0000.98%
Opaleye Management Inc. 2,000,000$5,258,0000.87%
Rubric Capital Management LP 3,000,000$8,190,0000.52%
Prosight Management, LP 256,115$699,0000.44%
ACT CAPITAL MANAGEMENT, LLC 185,000$506,0000.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,489,000$14,985,0000.22%
GSA CAPITAL PARTNERS LLP 363,887$993,0000.11%
KNOTT DAVID M 80,000$218,0000.08%
Hudson Bay Capital Management LP 1,540,000$4,204,0000.05%
APOGEM CAPITAL LLC 19,401$53,0000.03%
View complete list of SIO GENE THERAPIES INC shareholders